Work

Sa1200 REDUCED RISK OF BARRETT'S ESOPHAGUS WITH SGLT2 INHIBITORS/GLP1 RECEPTOR AGONISTS WHEN COMPARED TO METFORMIN ALONE: A NATIONAL DATABASE STUDY

Year: 2020

Type: conference-abstract

Source: Gastroenterology

DOI: 10.1016/s0016-5085(20)31472-4

Authors: Apoorva K. Chandar, Omar A. Alaber, Aman Rajpal, Amitabh Chak

Language: English

Topic: Esophageal Cancer Research and Treatment

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3027158158

Cites:

Cited by:

Related to: 10